Extending natalizumab up to eight weeks ‘safe and effective’
Extending natalizumab up to eight weeks ‘safe and effective’
In a study of 1,964 patients with multiple sclerosis, researchers at the NYU Langone Multiple Sclerosis Comprehensive Care Center found that extending the dose of natalizumab from four weeks up to eight weeks was shown to be well-tolerated and effective in patients, and resulted in no cases of the potentially fatal side effect progressive multifocal leukoencephalopathy (PML)..... Read More - http://www.ms-uk.org/tysabri
MS-UK - http://www.ms-uk.org/